Trial Profile
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2009
Price :
$35
*
At a glance
- Drugs PRX 08066 (Primary)
- Indications Chronic obstructive pulmonary disease; Pulmonary hypertension
- Focus Therapeutic Use
- 31 Jul 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 May 2008 New trial record.